Advertisement
Annovis Bio Says FDA Authorizes Phase 2/3 Trial For Buntanetap In Alzheimer's Disease
(RTTNews) - Annovis Bio, Inc. (ANVS), a late-stage clinical drug platform company, announced Thursday that the U.S. Food and Drug Administration (FDA) has authorized the Phase 2/3 clinical study of buntanetap in moderate Alzheimer's Disease (AD).
Following the submission of the Phase 2a clinical safety data and the chronic toxicology data in animals, the Company requested approval to further pursue the development of buntanetap in AD.
The FDA approved the Company's development plan, study protocol and authorized the initiation of the Phase 2/3 clinical study of buntanetap in AD.
For More Such Health News, visit rttnews.com
read more
Annovis Bio Says Phase III Study Data Release For Buntanetap In Parkinson's Disease Postponed
Drug platform company Annovis Bio, Inc. (ANVS) announced Wednesday a postponement in the Phase III study data release for buntanetap in Parkinson's Disease. This adjustment is due to ongoing data cleaning efforts to ensure the accuracy and reliability of the study results.
RTTNews
|
il y a 568
European Shares Extend Gains With Focus On Putin-Trump Talks
European stocks held near five-month highs on Friday amid hopes the Trump-Putin summit in Alaska might help end the war in Ukraine.
RTTNews
|
il y a 9 minutes
Asian Shares Mostly Higher With Ukraine Talks In Focus
Asian stocks ended mostly higher on Friday as investors reacted to mixed economic data from China and Japan, and awaited the outcome of the Alaska summit between U.S. and Russian Presidents.
RTTNews
|
il y a 31 minutes
China Economic Data Disappoints
China's industrial production, retail sales and fixed asset investment registered weaker-than-expected growth in July, strengthening calls for further policy support to rebalance the economy towards consumption. Industrial production grew 5.7 percent in July from a year ago, following June's 6.8 percent increase, the National Bureau of Statistics reported Friday.
RTTNews
|
il y a 59 minutes
Yen Rises Against Majors
The Japanese yen strengthened against other major currencies in the Asian session on Friday.
RTTNews
|
il y a 1h 12min
NZ Dollar Falls On Soft China Data
The New Zealand dollar weakened against other major currencies in the Asian session on Friday, after China's industrial production and retail sales logged slower growth in July.
RTTNews
|
il y a 1h 37min
NZ Dollar Falls Against Majors
The New Zealand dollar weakened against other major currencies in the Asian session on Friday.
RTTNews
|
il y a 2h 24min
European Shares Seen Tad Higher As World Braces For Alaska Talks
European stocks are seen opening higher on Friday after the S&P 500 index closed at a new record high for the third consecutive day overnight despite concerns about slowing consumer spending.
RTTNews
|
il y a 3h 34min
